News Focus
News Focus
Followers 473
Posts 24013
Boards Moderated 0
Alias Born 02/05/2004

Re: brickbybrick post# 91425

Tuesday, 01/07/2014 9:31:48 PM

Tuesday, January 07, 2014 9:31:48 PM

Post# of 130524
nice drill down - I saw that as well

http://biz.yahoo.com/e/130613/ambs8-k.html

Item 8.01 Other Events

On May 22, 2013, the Company entered into a letter of intent to in-license a Phase 2 drug candidate in L-Dopa-Induced Dyskinesia Parkinson’s Disease from an undisclosed third party. Once licensed the Company intends to initiate a Phase 2b clinical trial within 12 months.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y